|
|||||
|
|
Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial |
|
| Authors: | Thomas Menter Stefanie Hayoz Emanuele Zucca Eva Kimby Stefan Dirnhofer Alexandar Tzankov |
| Affiliation: | 1. Institute of Pathology and Medical Genetics, University Hospital Basel, Bern, Switzerland;2. SAKK Coordinating Center, Bern, Switzerland;3. Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland Institute of Oncology Research, Bellinzona, Switzerland Department of Medical Oncology, Inselspital/Bern University Hospital, Bern, Switzerland;4. Division of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden |
| Abstract: | |
| Keywords: | follicular lymphoma gene expression profiling lenalidomide RORγt Th17 T cells |